Projected Earnings Date: 2024-08-09    (Delayed quote data   2025-09-16)
Last
 2.52
Change
 ⇑ +0.40   (+18.87%)
Volume
  17,407,572
Open
 2.61
High
 2.88
Low
 2.22
8EMA (Daily)
 1.35
40EMA (Daily)
 0.85
50EMA (Daily)
 0.83
STO (Daily)
 42.341
MACD Hist (Daily)
 0.370
8EMA (Weekly)
 1.112
40EMA (Weekly)
 0.99
50EMA (Weekly)
 1.07
STO (Weekly)
 34.578
MACD Hist (Weekly)
 0.284
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com